NO961677L - Nye cykloheksanforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem - Google Patents

Nye cykloheksanforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Info

Publication number
NO961677L
NO961677L NO961677A NO961677A NO961677L NO 961677 L NO961677 L NO 961677L NO 961677 A NO961677 A NO 961677A NO 961677 A NO961677 A NO 961677A NO 961677 L NO961677 L NO 961677L
Authority
NO
Norway
Prior art keywords
preparation
methods
pharmaceutical compositions
compositions containing
cyclohexane compounds
Prior art date
Application number
NO961677A
Other languages
English (en)
Other versions
NO961677D0 (no
Inventor
David C Billington
Isabelle Picard
Ghanem Atassi
Alain Pierre
Michael Burbridge
Nicolas Guilbaud
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO961677D0 publication Critical patent/NO961677D0/no
Publication of NO961677L publication Critical patent/NO961677L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/64—Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C07C381/12—Sulfonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Forbindelser med formel (I): A B R C D hvor: j ¿ R er valgt fra radikalene: B, *3 R2 ,R3 og (a) (P) (7) ¿ Y er valgt fra ¿C¿ og ¿CH¿ , 00 \ R ¿ R, representerer radikalet O O og A, B, C, D, R2, R3 og R4 har forskjellige betyd- ninger, og også de mulige geometriske isomerer og/eller diastereomerer og/eller enantiomerer i ren form eller i form av en blanding. Medikamenter.
NO961677A 1995-04-27 1996-04-26 Nye cykloheksanforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem NO961677L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9505052A FR2733498B1 (fr) 1995-04-27 1995-04-27 Nouveaux composes cyclohexaniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
NO961677D0 NO961677D0 (no) 1996-04-26
NO961677L true NO961677L (no) 1996-10-28

Family

ID=9478495

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961677A NO961677L (no) 1995-04-27 1996-04-26 Nye cykloheksanforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Country Status (10)

Country Link
US (1) US5648382A (no)
EP (1) EP0739887A1 (no)
JP (1) JPH08295664A (no)
CN (1) CN1138040A (no)
AU (1) AU5083196A (no)
CA (1) CA2174892A1 (no)
FR (1) FR2733498B1 (no)
NO (1) NO961677L (no)
NZ (1) NZ286456A (no)
ZA (1) ZA963350B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002028862A2 (en) * 2000-10-02 2002-04-11 Emory University Triptolide analogs for the treatment of autoimmune and inflammatory disorders
US6919307B2 (en) * 2000-11-01 2005-07-19 Praecis Pharmaceuticals, Inc. Therapeutic agents and methods of use thereof for the modulation of angiogenesis
JP4212356B2 (ja) 2000-11-01 2009-01-21 プラエシス ファーマシューティカルズ インク． 血管新生を調節するための治療薬およびその使用方法
US7105482B2 (en) * 2000-11-01 2006-09-12 Praecis Pharmaceuticals, Inc. Methionine aminopeptidase-2 inhibitors and methods of use thereof
US6548477B1 (en) 2000-11-01 2003-04-15 Praecis Pharmaceuticals Inc. Therapeutic agents and methods of use thereof for the modulation of angiogenesis
US6958359B1 (en) * 2000-11-15 2005-10-25 Parker Hughes Institute Vanadium compounds as anti-angiogenic agents
WO2005066197A2 (en) * 2003-12-29 2005-07-21 Praecis Pharmaceuticals, Inc. Inhibitors of methionine aminopeptidase-2 and uses thereof
EP2240460A4 (en) * 2008-01-07 2012-02-22 Univ Emory BRANCHED DIEPXYDE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1258967A (no) * 1968-04-16 1972-01-05
CH505811A (de) * 1968-04-16 1971-04-15 Sandoz Ag Verfahren zur Herstellung eines bisher unbekannten Antibioticum-Derivates
JPH01233275A (ja) * 1988-03-11 1989-09-19 Taisho Pharmaceut Co Ltd 生理活性物質
PH26256A (en) * 1988-08-12 1992-04-01 Fujisawa Pharmaceutical Co Oxaspiro [2,5] octane derivative
US4954496A (en) * 1988-08-12 1990-09-04 Fujisawa Pharmaceutical Company, Ltd. Cyclohexane derivatives and pharmaceutical compositions
ATE106726T1 (de) * 1988-09-01 1994-06-15 Takeda Chemical Industries Ltd Angiogenese hemmendes mittel.
EP0387650B1 (en) * 1989-03-06 1993-03-31 Takeda Chemical Industries, Ltd. 6-epifumagillols, production and use thereof

Also Published As

Publication number Publication date
CA2174892A1 (fr) 1996-10-28
EP0739887A1 (fr) 1996-10-30
NZ286456A (en) 1997-09-22
CN1138040A (zh) 1996-12-18
AU5083196A (en) 1996-11-07
ZA963350B (en) 1996-11-04
US5648382A (en) 1997-07-15
NO961677D0 (no) 1996-04-26
FR2733498A1 (fr) 1996-10-31
JPH08295664A (ja) 1996-11-12
FR2733498B1 (fr) 1997-05-30

Similar Documents

Publication Publication Date Title
NO20005714D0 (no) Nye substituerte cykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
ES2044836T3 (es) Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene.
CA2157117A1 (en) Spirocyclic Piperidine Derivatives
PL275423A1 (en) Method of obtaining novel heterocyclic compounds
NO170280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater
ATE197672T1 (de) Arzneimittel gegen nervöse erkrankungen
ATE60579T1 (de) Pyrrolidinamid-derivate mit antipropylendopeptidase-wirkung, zusammenstellungen, die sie enthalten, verfahren zu ihrer herstellung und heilmittel, die sie enthalten.
ES2066781T3 (es) Nuevas n-(1-alquil-3-hidroxi-4-piperidinil)-benzamidas sustituidas.
CA2072785A1 (en) Pharmacologically active hydrazine derivatives and processes for the preparation thereof
DE69008142T2 (de) 4-Substituierten Imidazolen zur Senkung des intraokularen Druckes.
IL77452A0 (en) Derivatives of arylcyclobutylalkylamines,their preparation and pharmaceutical compositions containing them
NO961677L (no) Nye cykloheksanforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
HU9204130D0 (en) Thiazolodine derivatives, method for producing them and pharmaceutical preparatives containing such compounds
PT80817A (en) Process for the preparation of carbamates,thiocarbamates and dithiocarbamates and their substituted derivatives containing aromatic radicals
NO892295L (no) Fremgangsmaate for fremstilling av nye cefemforbindelser.
EP1057814A4 (en) TETRAHYDROBENZINDOLE DERIVATIVES
NO995594D0 (no) Nye substituerte heterocykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
UA41871C2 (uk) Похідні еритроміцину, спосіб їх одержання та фармацевтична композиція на їх основі
CA2118929A1 (en) (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
NO971424L (no) Nye heterocyklisk substituerte imidazolo-kinoksalinoner, deres fremstilling og anvendelse
WO2001072289A3 (de) Arzneimittel zur stimulierung der leukopoese, zur behandlung von tumor- und protozoenerkrankungen, von akarinosis, arthropodiasis und verfahren zu seiner herstellung
HUP9904526A2 (hu) Piperidinszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
WO2000008006A3 (en) Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them
FR2672592B1 (fr) Nouveaux esters de l'acide 3-(3,3,3-trifluoro 2-chloro propenyl) 2,2-dimethyl cyclopropanecarbonecarboxylique, leur procede de preparation et leur application comme pesticides.
NO922608L (no) Nye cefalosporinforbindelser og fremgangsmaater til deres fremstillin